| 1 |
LU1540961759 |
HBM UCITS (LUX) FUNDS - HBM Global Biotechnology Fund A Cap USD |
+1,74 % |
+18,68 % |
-0,02 |
| 2 |
LU1540962054 |
HBM UCITS (LUX) FUNDS - HBM Global Biotechnology Fund P Cap USD |
+1,22 % |
+19,52 % |
-0,05 |
| 3 |
LU0942225912 |
Candriam Equities L Biotechnology, R - Capitalisation |
+1,09 % |
+20,63 % |
-0,05 |
| 4 |
LU0133360163 |
Candriam Equities L Biotechnology, I - Capitalisation |
+0,76 % |
+20,45 % |
-0,07 |
| 5 |
LU1897414642 |
Janus Henderson Horizon Biotechnology Fund E2 USD |
+1,03 % |
+27,63 % |
-0,04 |
|
|
| 33 |
LU0069152568 |
UBS (Lux) Equity Fund - Biotech (USD), Anteilsklasse P-acc, USD |
-3,64 % |
+22,15 % |
-0,26 |
|
|
| 79 |
DE000A3DCA95 |
BIT Biotech Opportunities S |
-31,22 % |
+30,97 % |
-1,08 |
| 80 |
DE000A3DCBA0 |
BIT Biotech Opportunities I-II |
-31,41 % |
+30,94 % |
-1,09 |
| 81 |
LU0767968745 |
Bellevue Funds (Lux) - Bellevue Obesity Solutions I GBP - Accumulating |
-9,92 % |
+12,12 % |
-1,00 |
| 82 |
LU0415392835 |
Bellevue Funds (Lux) - Bellevue Obesity Solutions I CHF - Accumulating |
-13,00 % |
+14,05 % |
-1,08 |
| 83 |
LU0415392595 |
Bellevue Funds (Lux) - Bellevue Obesity Solutions B CHF - Accumulating |
-13,61 % |
+14,05 % |
-1,12 |